Latest Private Placement News

Anteris Technologies has secured regulatory green lights for its pivotal PARADIGM trial and raised $25.2 million in capital, advancing its innovative DurAVR® transcatheter heart valve towards commercialisation.

EV Resources is advancing its Los Lirios antimony project with drilling set to begin in January 2026 and engineering nearing completion for the Tecomatlán processing plant refurbishment, aiming for production by mid-2026.

Control Bionics has secured $3.25 million through a discounted share placement, aiming to boost its assistive and neurotechnology product growth globally.

OpenLearning has strengthened its foothold in the Philippines through a strategic investment from CE Nexus, a division of leading publisher C&E Publishing, aiming to boost growth in Southeast Asia's education technology market.

Anteris Technologies Global Corp. has filed a Form S-1 registration statement with the SEC to enable resale of shares issued in a recent private placement, marking a key step in advancing its DurAVR transcatheter heart valve system and pivotal clinical trials.

Viridis Mining and Minerals has locked in a US$30 million strategic funding agreement with Brazilian asset managers Régia Capital and ORE Investments, setting a clear path to Final Investment Decision for its Colossus rare earth project.

AustChina Holdings has raised $1.5 million through a private placement with Bluestone Energy, aiming to accelerate acquisitions and exploration across its energy and mineral projects.

Kincora Copper Limited has closed a C$4 million non-brokered financing and expanded its exploration portfolio with eight active projects, advancing drilling programs alongside major partners. The company reported a net loss of CAD 2.786 million for the nine months ended September 30, 2025.

Marimaca Copper Corp. reports a robust working capital position supported by recent capital raises, while managing a complex receivable linked to a liquidation process. The company remains well-positioned to fund operations over the next year but faces uncertainties beyond that horizon.

Anteris Technologies Global Corp. reported a $22.2 million loss in Q3 2025 while progressing its DurAVR Transcatheter Heart Valve pivotal trial following key regulatory approvals. The company bolstered its cash position with a $25.2 million private placement post-quarter.

Paladin Energy reported a reduced net loss of US$9.9 million for Q1 FY2026 and completed a significant A$300 million equity raise to fund key uranium projects. The company also faces shareholder class actions alleging misleading production guidance.

Mayfield Group Holdings has completed a $30.5 million private placement and launched a $3 million share purchase plan to fund growth initiatives, including acquisitions and capacity expansion.